494120.KQ Curiosis
- Market cap
- KRW 135B
- P/E
- -
- P/B
- 5.47x
- ROE
- -28.8%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 494120.KQ undervalued?
Graham numberThe Graham number of Curiosis cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Curiosis fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-28.8%), below 10%.
ROA 0/1
Return on assets (-22.3%) is below the industry median (-9.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-36.7%) is below the industry median (-3.8%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.0%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 2/2
Cash covers 2.0 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (5.5x) is above the industry median (3.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Curiosis stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Curiosis
Curiosis, Inc. develops, produces, and supplies laboratory equipment in the field of life science. It offers cell imaging, cell counting, cell isolation, and digital pathology products. The company was incorporated in 2015 and is based in Seoul, South Korea.
Full company profileCuriosis financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Curiosis annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|
| Income Statement | |||
| Revenue | 5.41B | 7.30B | 9.24B |
| Gross Profit | 2.21B | 3.49B | 2.24B |
| Operating Income | -6.20B | -7.53B | -6.95B |
| EBITDA | -2.21B | -6.64B | -5.76B |
| Net Income | -4.82B | -7.86B | -7.11B |
| EPS | -756 | -1,034 | -466 |
| Balance Sheet | |||
| Total Assets | 17.4B | 34.2B | 31.9B |
| Total Liabilities | 7.66B | 6.03B | 7.22B |
| Shareholders' Equity | 9.71B | 28.2B | 24.7B |
| Cash & Short-term Investments | 9.23B | 23.8B | 17.0B |
| Cash Flow | |||
| Operating Cash Flow | -4.78B | -7.35B | -6.06B |
| Capital Expenditure | 460M | 2.31B | 2.43B |
| Free Cash Flow | -5.24B | -9.66B | -8.48B |
| Ratios | |||
| ROE | -49.6% | -27.9% | -28.8% |
| ROA | -27.7% | -23.0% | -22.3% |
| Net Profit Margin | -89.0% | -107.7% | -77.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Curiosis dividends
Curiosis has not paid dividends in the last 2 fiscal years.
Last stock split: 2:1 on Jul 15, 2026.
Who owns Curiosis
- Insiders 14.35%
- Institutions 4.93%
- Public & others 80.72%
- Shares outstanding 15.3M
- Free float 11.1M
Curiosis company profile
- Company name
- Curiosis
- Ticker
- 494120.KQ
- ISIN
- KR7494120009
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 96
- Fiscal year end
- December
- Address
- 10 Teheran-ro 38-gil, Seoul, South Korea, 06221
- Phone
- 82 2 508 5236
- Website
- curiosis.com
About Curiosis
Curiosis, Inc. develops, produces, and supplies laboratory equipment in the field of life science. It offers cell imaging, cell counting, cell isolation, and digital pathology products. The company was incorporated in 2015 and is based in Seoul, South Korea.
Curiosis management
10- Mr. Hoyoung Yun Ph.D.CEO, President & Director · born 1980
- Mr. Daesung Hur M.S.COO, Executive VP & Director · born 1970
- Mr. Youngho Park Ph.D.Senior VP & CTO · born 1979
- Mr. Heedon Ahn M.B.A.CSO & Executive VP · born 1968
- Mr. Jungmin Cho M.B.A.Senior VP & Head of Sales and Marketing Division · born 1978
- Mr. Changyong Um Ph.D.Executive VP, CRO & Director · born 1969
- Mr. Jeongmin KimSenior VP & Head of Business Administration Dept. · born 1977
- Mr. Chihyoung Shim M.S.VP & Head of Information Security Dept. · born 1981
- Mr. SungUk ChoiAuditor · born 1976
- Dongyoub Baek Ph.D.Director & Head of SW Dept.